Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ReGear Life Sciences, a developer of the ReBound Therapeutic Warming System, has closed a $2.5 million series A financing round following a $1 million investment by Stonewood Capital Management.
Subscribe to our email newsletter
According to ReGear, the funds will be used to drive growth and further expansion into the global sports medicine, physical medicine, rehabilitation, and chiropractic markets, and develop products for the home care markets.
ReBound is a compact, portable, and simple-to-use therapeutic warming system that utilizes patented ReGear Diathermy technology. ReBound can be used to treat virtually any condition for which thermotherapy is indicated, including muscle spasms, joint contractures and pain associated with a variety of conditions such as osteoarthritis, soft tissue injuries, back disorders and more, the company said.
James Hanlon, ReGear’s president and CEO, said: “Given the current condition of the financial markets and the economy we are fortunate to have been able to attract such a great group of angel investors and close out the round with an investor as respected as Stonewood.”